Eli Lilly has tapped telehealth startup Ro to distribute its single-dose Zepbound vials

Through a new re­la­tion­ship with Eli Lil­ly, Ro pa­tients can now get eas­i­er ac­cess to the drug­mak­er’s dis­count­ed, sin­gle-dose vials of block­buster obe­si­ty drug Zep­bound …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.